JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211422200 on January 27, 2003

J. Biol. Chem., Vol. 278, Issue 14, 11985-11994, April 4, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/14/11985    most recent
M211422200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeVries, M. E.
Right arrow Articles by Kelvin, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeVries, M. E.
Right arrow Articles by Kelvin, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Genomic Organization and Evolution of the CX3CR1/CCR8 Chemokine Receptor Locus*

Mark E. DeVriesDagger §, Henian Cao||**, Jian Wang||**, Luoling XuDagger , Alyson A. KelvinDagger , Longsi RanDagger , Luan A. Chau**, Joaquin Madrenas§**, Robert A. Hegele||**, and David J. KelvinDagger §Dagger Dagger

From the Dagger  Division of Experimental Therapeutics, and Department of Immunology, University of Toronto, University Health Network, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontario M5G 2C4, Canada, the Departments of § Microbiology and Immunology and of || Biochemistry, University of Western Ontario, London, Ontario N6A 5C1, Canada, and ** Robarts Research Institute, London, Ontario N6G 2V4, Canada

The chemokine receptors CCR8 and CX3CR1 are key players in adaptive immunity and are co-receptors for human immunodeficiency virus. We describe here the genomic organization and evolutionary history of both of these genes. CX3CR1 has three promoters that transcribe three separate exons that are spliced with a fourth exon containing the coding region. CCR8 has two promoters. One promoter produces a transcript of two spliced exons, and the other promoter transcribes an exon containing the coding region and lacks introns. We analyzed these promoters in the context of a luciferase reporter and identified several positive and negative regulatory elements. Identification of the genomic organization of these genes in mouse demonstrates a similar organization for CCR8, but mouse CX3CR1 lacks two of the human promoters and has an additional mouse-specific promoter that transcribes only the exon containing the coding region and therefore resembles the organization of the human and mouse CCR8 genes. We also identify two nontranscribed regions that are highly conserved between human and mouse CX3CR1 containing possible regulatory elements. Examination of the CX3CR1 and CCR8 genes and surrounding genomic regions indicates that these genes are the result of the duplication of an ancestral gene prior to the divergence of teleost fish. We characterize single nucleotide polymorphisms in the promoters of human CCR8 and CX3CR1 and establish linkage relationships between CX3CR1 promoter polymorphisms and two previously described CX3CR1 coding polymorphisms associated with human immunodeficiency virus disease progression and arteriosclerosis susceptibility.


* This work was supported by grants from the Heart and Stroke Foundation of Canada, Genome Canada, the Canadian Institutes of Health Research (CIHR), and a special award from the Robarts Research Institute (London, Ontario, Canada).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY016370.

A CIHR scholar.

Dagger Dagger To whom correspondence should be addressed: Division of Experimental Therapeutics, Toronto General Hospital, 200 Elizabeth St., MBRC5R425, Toronto, Ontario M5G 2C4, Canada. Tel.: 416-340-4800 (ext. 6984); E-mail: dkelvin@uhnres.utoronto.ca.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
J. Barlic, Y. Zhang, J. F. Foley, and P. M. Murphy
Oxidized Lipid-Driven Chemokine Receptor Switch, CCR2 to CX3CR1, Mediates Adhesion of Human Macrophages to Coronary Artery Smooth Muscle Cells Through a Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Pathway
Circulation, August 22, 2006; 114(8): 807 - 819.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Madsen and C. M. Stoltzfus
An Exonic Splicing Silencer Downstream of the 3' Splice Site A2 Is Required for Efficient Human Immunodeficiency Virus Type 1 Replication
J. Virol., August 15, 2005; 79(16): 10478 - 10486.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Barlic, D. H. McDermott, M. N. Merrell, J. Gonzales, L. E. Via, and P. M. Murphy
Interleukin (IL)-15 and IL-2 Reciprocally Regulate Expression of the Chemokine Receptor CX3CR1 through Selective NFAT1- and NFAT2-dependent Mechanisms
J. Biol. Chem., November 19, 2004; 279(47): 48520 - 48534.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.